Douglas John Karas - 09 Mar 2022 Form 4 Insider Report for Nascent Biotech Inc.

Role
Director
Signature
/s/ Douglas Karas
Issuer symbol
NBIO on OTC
Transactions as of
09 Mar 2022
Net transactions value
+$15,000
Form type
4
Filing time
04 Apr 2022, 16:01:45 UTC
Previous filing
20 Aug 2021
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $15,000 +300,000 +27% $0.0500* 1,427,853 09 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.